KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Deferred Taxes (2017 - 2019)

Historic Deferred Taxes for Amneal Pharmaceuticals (AMRX) over the last 3 years, with Q4 2019 value amounting to $33000.0.

  • Amneal Pharmaceuticals' Deferred Taxes rose 11006.1% to $33000.0 in Q4 2019 from the same period last year, while for Sep 2020 it was $33000.0, marking a year-over-year decrease of 9999.11%. This contributed to the annual value of $371.7 million for FY2019, which is 403808.67% up from last year.
  • According to the latest figures from Q4 2019, Amneal Pharmaceuticals' Deferred Taxes is $33000.0, which was up 11006.1% from $389.9 million recorded in Q3 2019.
  • In the past 5 years, Amneal Pharmaceuticals' Deferred Taxes registered a high of $389.9 million during Q3 2019, and its lowest value of -$14.5 million during Q2 2018.
  • Its 3-year average for Deferred Taxes is $36.3 million, with a median of -$420000.0 in 2018.
  • The largest annual percentage gain for Amneal Pharmaceuticals' Deferred Taxes in the last 5 years was 652856.17% (2019), contrasted with its biggest fall of 183046.88% (2019).
  • Amneal Pharmaceuticals' Deferred Taxes (Quarter) stood at $1.3 million in 2017, then plummeted by 125.71% to -$328000.0 in 2018, then skyrocketed by 110.06% to $33000.0 in 2019.
  • Its last three reported values are $33000.0 in Q4 2019, $389.9 million for Q3 2019, and -$8.3 million during Q2 2019.